Tag: TCAR
Debate verdict: Carotid endarterectomy maintains its golden hue
The established “gold-standard” approach to carotid revascularization remained enshrined as the go-to operation as far as a 2025 Charing Cross (CX) International Symposium audience...
Reflections from VESS: Internal mentoring, external inspiration and really good skiing
Just over a week ago, I was racing my medical school vascular surgery attending, Dr. Adam Doyle, down a Breckenridge run memorably named “The...
InspireMD and NAMSA to partner on CGUARDIANS II pivotal clinical trial
InspireMD and North American Science Associates (NAMSA) today announced that, pursuant to a previously announced strategic outsourcing partnership, the companies are working together to conduct...
ROADSTER 3 provides key evidence that ‘goes beyond registry data’ on...
Thirty-day results from the ROADSTER 3 study have demonstrated that transcarotid artery revascularization (TCAR) is a safe and effective approach in patients who are...
Novel measure suggests 20% of elective carotid revascularizations fail to achieve...
One in five patients failed to achieve a textbook outcome after undergoing carotid endarterectomy (CEA), transcarotid artery revascularization (TCAR) or transfemoral carotid artery stenting...
InspireMD receives IDE approval from FDA for CGUARDIANS II pivotal trial
InspireMD has announced that the Food and Drug Administration (FDA) approval of the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS II...
Boston Scientific completes acquisition of Silk Road Medical
Boston Scientific announced the close of its acquisition of Silk Road Medical, the company behind transcarotid artery revascularization (TCAR).
"The integration of the TCAR platform into our portfolio...
Silk Road celebrates milestone of 100,000 TCAR procedures
Silk Road Medical has announced the milestone of more than 100,000 transcarotid artery revascularisation (TCAR) procedures having been performed to date.
“A growing number of...
CEA and TCAR should be ‘first-line’ interventions for weekend carotid revascularization,...
Patients who undergo carotid revascularization at the weekend have increased odds of complications and mortality, with transfemoral carotid artery stenting (TFCAS) posing the highest...
The top 10 most popular Vascular Specialist stories of June 2024
In June, the most read stories from Vascular Specialist included key reports from the 2024 Vascular Annual Meeting (VAM; June 19–22) covering TEVAR, CEA...
Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and...
High stroke and death rates relating to carotid stenting in the Pacific Northwest may be driven by the selection of high-risk patients with less...
TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes...
A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable choice” in severe chronic...
TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes...
A study examining outcomes between different carotid revascularization procedures has concluded that transcarotid artery revascularization (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable...
Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and...
High stroke and death rates relating to carotid stenting in the Pacific Northwest may be driven by the selection of high-risk patients with less...
Boston Scientific announces agreement to acquire Silk Road Medical
Boston Scientific has announced that it has entered into a definitive agreement to acquire Silk Road Medical, a medical device company involved in producing...
CEA vs TCAR: Surgeons should be familiar with both procedures and...
When it comes to the ongoing debate of carotid endarterectomy (CEA) versus transcarotid artery revascularization (TCAR) in the treatment of carotid artery stenosis, operators...
Single-center analysis suggests improved longer-term outcomes with endarterectomy versus TCAR
A large, single-center analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated...
ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy
This year’s International Stroke Conference (Feb. 7–9) in Phoenix, Arizona, hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...
Coding: Increasing complexity and lost RVUs—a drop in the ocean?
A vascular surgery team at Audie L. Murphy VA Medical Center in San Antonio, Texas, uncovers “staggeringly low” numbers of correctly coded billing for...
Carotid stenting rebuttal: Those who live in glass houses…
Christopher J. White, MD, responds to a recent editorial by Malachi Sheahan III, MD, that took a critical look at the decision by the...
New survey shows transcarotid artery revascularization patients report faster recovery than...
This advertorial is sponsored by Silk Road Medical.
For Scott Berman, MD, patient responses when confronted with an explanation of the extent of their asymptomatic...
Carotid disease: Getting to the right decision
The recent move by the Centers for Medicare & Medicaid Services (CMS) to expand coverage for carotid artery stenting brought with it the requirement...
Rates of stroke, death and myocardial infarction post-TCAR do not differ...
While sex disparities regarding the outcomes of carotid revascularization have “long been a concern,” new prospective data published in the Journal of Vascular Surgery...
SVS urges members to make voices heard on CMS carotid stenting...
The SVS has created a template to help members transmit comments to the Centers for Medicare & Medicaid Services (CMS) regarding proposed major adjustments...
Safety benefits mean TCAR may be preferable approach in radiation-induced carotid...
A study set to be presented at VAM (14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery revascularization (TCAR)...
Global perspectives take center stage in second annual WFVS session at...
“The intellectual exchange of information and a better understanding of unique global perspectives has brought the leading societies closer,” Palma Shaw, MD, MBA, secretary...
More research needed but lithotripsy plus TCAR ‘an answer’ in certain...
Earlier this year, researchers debuted single-center experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularization (TCAR) into patients with...
Vascular community split over ‘death’ of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider, MD, professor of vascular and endovascular surgery at University of California San Francisco in San Francisco,...
Initial case series indicates lithotripsy can help TCAR expand into high-risk...
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
SCVS 2023: DAPT linked to better post-TCAR outcomes versus other drug...
Recent data presentations have revealed reduced risks of stroke and mortality among transcarotid artery revascularization (TCAR) patients who receive dual antiplatelet therapy (DAPT)—both preoperatively...
DAPT linked to better post-TCAR outcomes versus other drug regimens
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid disease...
Analysis finds no difference in TCAR outcomes between academic, community hospitals
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularization (TCAR) between academic and...
CEA, TCAR ‘continue to show superior outcomes’ to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularization, with CEA and transcarotid...
TCAR has ‘tremendous appeal’ as alternative to transfemoral carotid artery stenting
This video is sponsored by Silk Road Medical.
Richard Powell, MD, from Lebanon, New Hampshire, talks to Vascular Specialist at the Society for Vascular Surgery’s Vascular...
TCAR: First patient enrolled in ROADSTER 3 post-approval study
Silk Road Medical has announced enrollment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicenter, single-arm...
Low rate of new white lesions detected after TCAR using diffusion-weighted...
New white lesions are not a common occurrence in patients who have undergone transcarotid artery revascularization (TCAR), a study in which patients were assessed...
Silk Road to evaluate TCAR in standard surgical risk patients with...
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularization (TCAR) system in the treatment of standard surgical risk patients...
Early TCAR results in higher ipsilateral postoperative stroke rates when compared...
Adham Elmously, MD, a fellow at New York Presbyterian Hospital, New York, is set to present outcomes of early transcarotid artery revascularization (TCAR) vs....
Expanded Medicare coverage for TCAR in standard surgical risk patients...
Silk Road Medical today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery's Patient Safety...
FDA approves expanded indications for TCAR’s Enroute stent
The Food and Drug Administration (FDA) approved expanded indications for the Enroute stent system—part of the transcarotid artery revascularization (TCAR) procedure—to include patients at...
The top 10 most popular Vascular Specialist stories in February
February's top 10 includes a highlight from the 2022 Vascular and Endovascular Surgery Society (VESS) winter annual meeting and an interview with Melissa Kirkwood,...
Worldwide TCAR analysis provides ‘roadmap’ to evaluate future training approaches
An analysis of the worldwide experience of transcarotid artery revascularization (TCAR) has produced key objective proficiency metrics and an analytic framework to assess adequate...
VESS 2022: Novel use of TCAR to treat complex brachiocephalic disease...
A "unique" case series of patients undergoing transcarotid artery revascularization (TCAR) in which the system was put to novel use for proximal intervention or...
TCAR affords greater quality-adjusted life years than carotid endarterectomy, cost-effectiveness model...
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded...
SVS issues new guidelines covering carotid disease and popliteal aneurysms
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines for the management of extracranial cerebrovascular disease and popliteal artery aneurysms in...
‘TCAR yields high technical success with an extraordinarily low stroke and...
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularization (TCAR) treatment for carotid stenosis in the ROADSTER...
Study detects no difference in adverse outcomes from balloon dilatation strategy...
Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularization (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery...
TCAR may be associated with favorable outcomes in restenotic carotid lesions,...
Transcarotid artery revascularization (TCAR) may be associated with favorable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy (CEA), suggests a...
Analysis shows TCAR is more cost effective than CAS for carotid...
Transcarotid artery revascularization (TCAR) produces similar outcomes to the gold standard treatment for carotid stenosis—carotid endarterectomy (CEA)—but comes at a greater cost. This was...
TCAR has ‘statistically equivalent’ stroke and death outcomes to CEA, new...
Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularization (TCAR) for atherosclerotic carotid...
VAM: Industry-sponsored symposia
Industry-sponsored symposia at the Vascular Annual Meeting (VAM) will be presented Wednesday and Thursday evenings and at three breakfast sessions taking place Thursday morning....
VESS session: ‘Concerted effort’ made to feature science, discussion from widest...
At its very essence, says Vascular & Endovascular Surgery Society (VESS) President Jason T. Lee, MD, vascular surgery is a “social sport.” The specialty...
The top 10 most popular Vascular Specialist stories in May
A pointed letter aimed at electronic health record (EHR) behemoth Epic, an argument in favor of endovascular treatment of ruptured abdominal aortic aneurysms (rAAAs)...
TCAR vs CEA: Research shows fewer myocardial infarctions after TCAR with...
A Vascular Quality Initiative (VQI) analysis uncovered a reduction in the risk of myocardial infarction after transcarotid artery revascularization (TCAR) compared to carotid endarterectomy...
Hospital availability of TCAR associated with an improvement in overall outcomes...
Silk Road Medical has announced positive results from a comparative-effectiveness study involving transcarotid artery revascularization (TCAR) that was published in JAMA Network Open.
The study...
Study: The ‘successful’ operation of TCAR in a community practice setting
A research team in Dallas demonstrated the successful operation of transcarotid artery revascularization (TCAR) in a community practice setting, reporting results in line with...
Three weeks remain of VQI virtual sessions
SVS ONLINE—the virtual meeting staged by the Society for Vascular Surgery (SVS)—may be completed, but the Vascular Quality Initiative (VQI) virtual sessions have three...
TCAR outperforms transfemoral carotid artery stenting, ‘significantly’ lowering stroke and death...
A study that set out to determine whether there was a lesser stroke or death risk by deploying transcarotid artery revascularization (TCAR) over the...
Future is now: Surgical simulation utilizing 3D printing has potential to...
HOUSTON—The picture as Jonathan Stone, MD, describes it couldn’t be more stark. Medical error, according to recent publications, he says, now sits at third...